Skip to main content
Clinical Trials/NCT04756856
NCT04756856
Terminated
Not Applicable

Impact of a Muscle-targeted Nutritional Therapy in the Recovery of Post-discharge COVID19 Patients Suffering From Sarcopenia

Fondazione IRCCS Policlinico San Matteo di Pavia1 site in 1 country5 target enrollmentApril 21, 2021
ConditionsSarcopenia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sarcopenia
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Enrollment
5
Locations
1
Primary Endpoint
Physical performance - chair-stand
Status
Terminated
Last Updated
last year

Overview

Brief Summary

To assess the impact of a muscle-targeted nutritional therapy consisting of nutritional counseling and high-quality whey protein-based oral nutritional supplements enriched with leucine and vitamin D, on the recovery of post-COVID-19 patients

Registry
clinicaltrials.gov
Start Date
April 21, 2021
End Date
May 3, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Responsible Party
Principal Investigator
Principal Investigator

Emanuele Cereda

Principal investigator

Fondazione IRCCS Policlinico San Matteo di Pavia

Eligibility Criteria

Inclusion Criteria

  • Sarcopenia (revised European Working Group on Sarcopenia in Older People criteria)
  • Recent discharge from hospital for COVID-19
  • Informed consent

Exclusion Criteria

  • Any malignant disease during the last five years
  • Known kidney failure (previous glomerular filtration rate \<30 ml/min);
  • Known liver failure (Child B or C)
  • Psychiatric disease
  • Endocrine disorders associated with disorders of calcium metabolism (excluding osteoporosis)
  • Indications related to the study product:
  • More than 10 µg (400 IU) of daily Vitamin D intake from medical sources. More than 500 mg of daily calcium intake from medical sources. Adherence to a high energy or high protein diet up or use of protein containing or amino acid containing nutritional supplements up to three months before starting the study.
  • Known allergy to milk, milk products or other components of the proposed interventions
  • Indication to or ongoing artificial nutrition support
  • Inclusion in other nutrition intervention trials

Outcomes

Primary Outcomes

Physical performance - chair-stand

Time Frame: 12 weeks

Change in chair-stand test

Secondary Outcomes

  • Total body muscle mass(24 weeks)
  • Appendicular muscle mass(24 weeks)
  • Fatigue(24 weeks)
  • Body weight(24 weeks)
  • Functional status - muscle strength(24 weeks)
  • Self-perceived quality of life(24 weeks)
  • Serum levels of 25-hydroxy-vitamin D(24 weeks)
  • Physical performance - chair-stand(24 weeks)
  • Energy intake(24 weeks)

Study Sites (1)

Loading locations...

Similar Trials